Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States
Clinical trial NCT07214857 · COMPLETED
Trial details
- NCT number
- NCT07214857
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-29
- Primary completion
- 2024-10-09
- Enrollment
- 1385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.